Corinne Le Goff, MBA, PharmD

Dr. Corinne Le Goff was appointed President, CEO, and Director of Imunon on July 18, 2022. She brings decades of global healthcare leadership experience across a range of therapeutic areas including oncology, vaccines, immunology and CNS. Dr. Le Goff was previously Chief Commercial Officer of Moderna and was responsible for developing all capabilities for global distribution of Moderna’s COVID-19 vaccine. Prior to this, she served as U.S. Business President at Amgen, and also as SVP of Global Product Strategy & Commercial Innovation and as President of the Europe Region. Before this, she held several senior roles at Roche, including President of Roche France, and Global Product Strategy Head of Neuroscience & Rare Diseases. Early in her career, she held leadership roles at Sanofi and Pfizer in the U.S. Dr. Le Goff earned a Doctorate in Pharmacy from Rene Descartes University and an MBA from Sorbonne University and INSEAD. She was named a Chevalier de la Légion d’Honneur in 2014.